Study of Birinapant in Combination With Conatumumab in Subjects With Relapsed Ovarian Cancer

Clinical trial NCT01940172 · COMPLETED

Trial details

NCT number: NCT01940172
Sponsor: TetraLogic Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Relapsed Epithelial Ovarian Cancer Relapsed Primary Peritoneal Cancer Relapsed Fallopian Tube Cancer

Start date: 2013-11-01
Primary completion: 2015-09-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.